Preclinical studies show that inhibiting TNF-α can improve cognitive function and reduce neuroinflammation in animal models of AD and stroke, highlighting its potential as a therapeutic target for neurovascular diseases [1230, 1236]. This evidence concerns the gene TNF and Stroke.